-
Survivor Profile
A Cause for ConcernMargie Wilson is helping Black women understand their risk for endometrial cancer and teaching them not to ignore the warning signs.
by Taayoo Murray
-
Healthy Habits
Plant PowerPlant-based diets may help people with prostate cancer reduce their risk for disease progression.
by Anne Danahy
-
Forward Look
Cognition and Prostate CancerAndrogen deprivation therapy, a common prostate cancer treatment, may increase cognitive difficulties.
by Joseph Jalkiewicz
-
Rethinking the Role of RadiationChest radiation may not be necessary for people with intermediate-risk breast cancer.
by Thomas Celona
-
Get Involved
Treasure TroveThe Pediatric Oncology Treasure Chest Foundation provides toys and gifts to young cancer patients.
by Thomas Celona
-
Study Highlights Challenges in Pancreatic Cancer StagingMost pancreatic ductal adenocarcinoma cases initially considered to be stage I are changed to a higher stage after surgery.
by Taneia Surles
-
Understanding How High and Low Testosterone Levels Can Treat Prostate CancerUsing high-dose testosterone after prostate cancer stops responding to androgen deprivation therapy can stop tumor growth.
by Sandra Gordon
-
Understanding the Federal Rule on Breast Tissue Density ReportsScreening mammography reports will include breast density and an explanation in common language.
by Sandra Gordon
-
Forward Look
The Cost of Dental Side EffectsHead and neck cancer survivors often face significant costs for treatments not covered by health insurance.
by Kris Conner
-
Forward Look
A More Targeted PARP InhibitorEarly research suggests treatment could have higher potency and less toxicity for people with BRCA-related cancers.
by Marci A. Landsmann
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
